ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018
Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer.
Open access · bronzeAbstract read
In one paragraph
Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.
0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
60 citing papers in PubMed, 100 citations in OpenAlex.
- A maintained absolute lymphocyte count predicts the overall survival benefit from eribulin therapy, including eribulin re-administration, in HER2-negative advanced breast cancer patients: a single-institutional experience.Breast cancer research and treatment · 2020Trial
- A mammary-specific microfluidic device for studying post-radiotherapy vascular-immune cell interactions.bioRxiv : the preprint server for biology · 2026Article
- Unlocking the predictive value of post-neoadjuvant immune biomarkers in breast cancer: neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII).Breast cancer research and treatment · 2026Article
- Reduced Peripheral Blood Natural Killer Cell Proportion Predicts Poor Overall Survival in Advanced Gastric Cancer Patients Treated With Apatinib.World journal of oncology · 2025Article
- A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death.NPJ breast cancer · 2025Article
- Longitudinal Analyses and Predictive Factors of Radiation-Induced Lymphopenia After Postmastectomy Hypofractionated Radiation Therapy for Breast Cancer: A Pooled Cohort Study of 2 Prospective Trials.Advances in radiation oncology · 2025Article
- Causal association of breast cancer with immune cells: new evidence from bi-directional Mendelian randomization using GWAS summary statistics.BMC cancer · 2025Article
- Radiation-Induced Lymphopenia and Its Impact on Survival in Patients with Brain Metastasis.Current oncology (Toronto, Ont.) · 2024Article
- Mechanisms underlying neutrophils adhesion to triple-negative breast cancer cells via CD11b-ICAM1 in promoting breast cancer progression.Cell communication and signaling : CCS · 2024Article
- Two nomograms constructed for predicting the efficacy and prognosis of advanced non‑small cell lung cancer patients treated with anti‑PD‑1 inhibitors based on the absolute counts of lymphocyte subsets.Cancer immunology, immunotherapy : CII · 2024Article
- The association of PD-L1 expression and CD8-positive T cell infiltration rate with the pathological complete response after neoadjuvant treatment in HER2-positive breast cancer.Breast cancer research and treatment · 2024Article
- Monitoring trends in the absolute lymphocyte count and the neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin.BMC cancer · 2024Article
- Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer.BMC women's health · 2024Article
- Peripheral NK cell count predicts response and prognosis in breast cancer patients underwent neoadjuvant chemotherapy.Frontiers in immunology · 2024Article
- Ultrafast power doppler ultrasound enables longitudinal tracking of vascular changes that correlate with immune response after radiotherapy.Theranostics · 2024Article
- Effect of Radiation Therapy on Composition of Lymphocyte Populations in Patients with Primary Breast Cancer.Journal of personalized medicine · 2023Article
- Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery.Scientific reports · 2023Article
- Irradiated Mammary Spheroids Elucidate Mechanisms of Macrophage-Mediated Breast Cancer Recurrence.Cellular and molecular bioengineering · 2023Article
- Predicting Severity of Radiation Induced Lymphopenia in Individual Proton Therapy Patients for Varying Dose Rate and Fractionation Using Dynamic 4-Dimensional Blood Flow Simulations.International journal of radiation oncology, biology, physics · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 7 institutions in 1 country.
Anosheh AfghahiDepartment of Medicine, University of Colorado School of Medicine, Aurora, Colorado. anosheh.afghahi@ucdenver.edu akurian@stanford.edu.
Natasha PuringtonQuantitative Science Unit, Stanford University School of Medicine, Stanford, California.
Summer S HanQuantitative Science Unit, Stanford University School of Medicine, Stanford, California.ORCID 0000-0002-2013-6883
Manisha DesaiQuantitative Science Unit, Stanford University School of Medicine, Stanford, California.
Emma PiersonDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
Maya B MathurQuantitative Science Unit, Stanford University School of Medicine, Stanford, California.
Tina SetoDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
Caroline A ThompsonPalo Alto Medical Foundation Research Institute, Palo Alto, California.
Joseph RigdonQuantitative Science Unit, Stanford University School of Medicine, Stanford, California.ORCID 0000-0001-6265-0752
Melinda L TelliDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
Sunil S BadveDepartment of Pathology and Laboratory Medicine, Indiana University, Indianapolis, Indiana.ORCID 0000-0001-8861-9980
Christina N CurtisDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
Robert B WestDepartment of Pathology, Stanford University School of Medicine, Stanford, California.
Kathleen HorstDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
Scarlett L GomezDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
James M FordDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
George W SledgeDepartment of Medicine, Stanford University School of Medicine, Stanford, California.
Allison W KurianDepartment of Health Research and Policy, Stanford University School of Medicine, Stanford, California. anosheh.afghahi@ucdenver.edu akurian@stanford.edu.
Stanford Medicine · USStanford University · USCancer Prevention Institute of California · USHarvard University · USIndiana University Health · USSan Diego State University · USUniversity of Colorado Denver · US
Funding
Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4MCALIFORNIA'S PARTICIPATION IN THE NATIONAL CANCER PREVENTION AND CONTRO PROGRAMU58DP000807 · DP · PUBLIC HEALTH INSTITUTE · PI SNIPES, KURT P · 2007 to 2011
$22.5MStanford Center for Clinical and Translational Education and Research (SCCTER)UL1UL1RR025744 · NCRR · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2008 to 2011
$22.4MUC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4MNCATS NIH HHS KL2 TR001444NCCDPHP CDC HHS U58 DP000807NCI NIH HHS HHSN261201000034CNCI NIH HHS HHSN261201000035CNCI NIH HHS HHSN261201000035INCI NIH HHS HHSN261201000140CNCI NIH HHS P30 CA124435NCRR NIH HHS UL1 RR025744
Abstract
PubMed holds no abstract for this paper.
Indexed as
Lymphocyte CountAdultAgedBiomarkersBiomarkers, TumorCaliforniaHumansLymphocytes, Tumor-InfiltratingMiddle AgedMortalityNeoplasm StagingPrognosisProportional Hazards ModelsRegistriesSEER ProgramTriple Negative Breast NeoplasmsBiomarkersBiomarkers, Tumor
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.